Ocean Biomedical (OCEA) Stock Statistics & Valuation Metrics

Ocean Biomedical has a market cap or net worth of $1.84M. The enterprise value is ―.

Ocean Biomedical has 166,010,800 shares outstanding. The number of shares has decreased by -2.65% in one year.

Ocean Biomedical’s return on equity (ROE) is 0.03 and return on invested capital (ROIC) is 0.00%.

The current PE Ratio of Ocean Biomedical is -4.61. Ocean Biomedical’s PEG ratio is 0.00.

In the last 12 months, Ocean Biomedical had revenue of 0.00 and earned -3.30M in profits. Earnings per share was -0.34.

In the last 12 months, operating cash flow was -4.18M and capital expenditures 0.00, giving a free cash flow of -4.18M billion.

Ocean Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Ocean Biomedical upcoming earnings date is ―, TBA Not Confirmed.

Ocean Biomedical as a current ratio of 0.02, with Debt / Equity ratio of -16.70%

In the past 12 months, Ocean Biomedical has paid 0.00 in taxes.

Ocean Biomedical EV to EBITDA ratio is 0.00, with an EV/FCF ratio of -7.54.

Ocean Biomedical has $0.00 in cash and marketable securities with $16.30M in debt, giving a net cash position of $16.30M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Ocean Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―